期刊文献+

TCR Vα23-Vβ13基因修饰T细胞及其特异性细胞毒活性研究 被引量:4

Specific cytotoxicity of TCR Vα23-Vβ13 gene-modified T-cells
下载PDF
导出
摘要 目的:分析弥漫大B细胞淋巴瘤(DLBCL)抗原特异T细胞受体(TCR)Vα23-Vβ13基因修饰T细胞后的体外特异性杀伤活性。方法:扩增并克隆已鉴定的DLBCL患者外周血中单克隆增殖T细胞的TCR Vβ13和TCR Vα23基因全长序列,构建TCR Vβ13-IRES-TCR-Vα23双基因重组质粒,经核转染的方法将其转染正常人T细胞,通过real-time PCR和Western blotting检测TCR Vβ13和TCR Vα23这2个外源基因在mRNA和蛋白水平的体外表达情况,并对TCR转基因T细胞进行体外细胞毒性检测。结果:经酶切分析和核酸序列测定证实重组质粒构建正确,转染正常人T细胞后,TCR Vβ13和TCR Vα23在mRNA及蛋白水平实现了共表达。转染后3 d,TCR转基因T细胞对DLBCL细胞株Toledo细胞的杀伤活性明显高于非特异细胞株Raji细胞和Molt-4细胞,显示出特异性细胞毒活性。结论:成功构建DLBCL相关抗原特异的TCR Vβ13-IRES-TCR Vα23双基因真核表达质粒;TCR基因修饰T细胞可获得特异性细胞毒活性。 AIM : To analyze the cytotoxicity of TCR Vα23 - Vβ13 gene - modified T - cells specific to diffuse large B- cell lymphoma(DLBCL) associated antigens in vitro. METHODS: The identified full -length TCR Vβ13 and Vα23 genes of monoclonally expanded T - cells in the peripheral blood from a DLBCL patient were amplified and cloned. The bicistronic recombinant plasmid TCR Vβ13 - IRES - TCR Vα23 was constructed and transfected into T - cells isolated from a healthy individual by NucleofectorTM technology. The mRNA expression of antigen - specific TCR Vα23 and Vβ13 genes and the corresponding proteins were determined by real -time PCR and Western blotting, respectively. The specific cytotoxicity of TCR gene - transferred T - cells in vitro was detected. RESULTS : The recombinant plasmid was constructed successfully and verified by restriction enzyme digestion and nucleotide sequencing. The co - expression of antigen - specific TCR Vα23 and Vβ13 genes at mRNA and protein levels in the transfected healthy T - cells were observed in vitro. Three days after transfection, the cytotoxicity of TCR gene - transduced CD3 + T - cells against Toledo ceils was significantly higher than that against Raji cells or Molt - 4 cells. The DLBCL - specific cytotoxic T - lymphocytes(CTL) were inducted. CONCLUSION : The bicistronic eukaryotic expression plasmid TCR Vβ13 - IRES - TCR Vα23 specific to DLBCL - asso- ciated antigens is constructed successfully. The TCR gene - transferred T - cells display the ability of DLBCL - specific cytotoxicity.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第2期260-267,共8页 Chinese Journal of Pathophysiology
基金 国家高技术研究发展计划资助项目(No.2006AA02Z114) 广东自然科学基金重点资助项目(No.05103293 No.9251063201000001)
关键词 弥漫大B细胞淋巴瘤 TCR转基因 细胞毒活性 Diffuse large B- cell lymphoma TCR gene transfer Cytotoxicity
  • 相关文献

参考文献13

  • 1尹青松,李扬秋,陈少华,杨力建,周羽竝,吴秀丽,李萡,张学利.抗原特异TCR Vα6-pIRES2-EGFP和TCRV β13-pIRES2-EGFP真核表达载体的构建及共转染研究[J].免疫学杂志,2009,25(1):1-5. 被引量:5
  • 2李扬秋.血液肿瘤免疫治疗学[M].第1版.北京:人民卫生出版社,2005.272-288.
  • 3李闯,吴秀丽,李扬秋,周羽竝,陈少华,杨力建,朱康儿.独特型TCR Vα1-pIRES-TCR Vβ8表达载体构建及体外表达[J].细胞与分子免疫学杂志,2008,24(1):30-33. 被引量:4
  • 4Yin Q,Tan H,Chen S,et al.Charaterization of conserved CDR3 sequence of TCR α-and β-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma[J].Hematology,2010,15(1):48-57.
  • 5罗羽宏,梁忠平,李接兴,李震东.肝癌术后早期应用胸腺肽α1对T淋巴细胞亚群的影响(英文)[J].中国病理生理杂志,2009,25(6):1117-1121. 被引量:6
  • 6Schultze JL,Seamon MJ,Michalak S,et al.Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro[J].Blood,1997,89(10):3806-3816.
  • 7Stopeck AT,Gessner A,Miller TP,et al.Loss of B7.2(CD86) and intracellular adhesion molecule 1(CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma[J].Clin Cancer Res,2000,6(10):3904-3909.
  • 8Morgan RA,Dudley ME,Wunderlich JR,et al.Cancer regression in patients after transfer of genetically engineered lymphocytes[J].Science,2006,314(5796):126-129.
  • 9Xue SA,Gao L,Thomas S,et al.Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials:engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice[J].Haematologica,2010,95(1):126-134.
  • 10Kleiman SE,Pastan I,Puck JM,et al.Characterization of an MDR1 retroviral bicistronic vector for correction of X2 linked severe combined immunodeficiency[J].Gene Ther,1998,5(5):671-676.

二级参考文献13

  • 1黄梅娟,李扬秋,陈少华,周羽竝,杨力建,韩素芳.T-ALL及T细胞株相关TCR Vβ基因谱系和克隆性分析[J].免疫学杂志,2004,20(6):439-442. 被引量:7
  • 2张秀敏,隋延仿,司少艳,李侠,黄杨,胡沛臻,葛伟.MAGE-3基因稳定转染的HHCC细胞系的建立及其mRNA的表达[J].细胞与分子免疫学杂志,2006,22(4):450-451. 被引量:3
  • 3周羽竝,黄梅娟,杨力建,陈少华,李扬秋.独特型TCR Vβ2 DNA疫苗的构建和体外表达检测[J].中国病理生理杂志,2006,22(7):1320-1323. 被引量:3
  • 4岑东芝,李扬秋,陈少华,杨力建,郁志.APL患者外周血TCR Vα亚家族T细胞分布和增殖特点[J].临床肿瘤学杂志,2007,12(2):81-84. 被引量:7
  • 5Kessels HW, Wolkers MC, Van den Boom MD, et al. Immunotherapy through TCR gene transfer[J]. Nat Immunol, 2001, 2(10) : 957 - 961.
  • 6Xue S, Gillmore R, Downs A, et al. Exploiting T cell receptor genes for cancer immunotherapy [ J ]. Clin Exp immunol, 2005, 139 ( 2 ) : 167 - 172.
  • 7Schumacher TNM. T-cell-receptor gene therapy[J]. Nat Rev Immunol, 2002, 2(7) : 512 -519.
  • 8Fujio K, Misaki Y, Setoguchi K, et al. Functional reconstitution of class 11 MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex[J]. J Immunol, 2000, 165( 1 ) : 528 -532.
  • 9Van der veken LT, Hagedoom RS, Van Loenen MM, et al. αβ T-cell receptor engineered γδ cells mediate effective antileukemic reactivity [J]. Cancer Res, 2006, 66(6): 3331 -3337.
  • 10Gladow M, Uckert W, Blankenstein T, et al. Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors[J]. Eur J Immunol, 2004, 34(7) : 1882 - 1891.

共引文献13

同被引文献41

  • 1黄梅娟,李扬秋,陈少华,杨力建,周羽竝,张涛.B-ALL病人TCR Vβ基因谱系和克隆性分析[J].肿瘤防治研究,2004,31(6):320-322. 被引量:7
  • 2Arden B,Clark S,Kabelitz D,et al.Human T-cell receptorvariable gene segment families[J].Immunogenetics,1995,42(6):455-500.
  • 3Rowen L,Koop BF,Hood L.The complete 685-kilobaseDNA sequence of the human beta T cell receptor locus[J].Science,1996,272(5269):1755-1762.
  • 4Gras S,Kjer-Nielsen L,Burrows SR,et al.T-cell receptorbias and immunity[J].Curr Opin Immunol,2008,20(1):119-125.
  • 5Kedzierska K,La Gruta NL,Stambas J,et al.Trackingphenotypically and functionally distinct T cell subsets via T cellrepertoire diversity[J].Mol Immunol,2008,45(3):607-618.
  • 6Rehermann B,Nascimbeni M.Immunology of hepatitis B virusand hepatitis C virus infection[J].Nature Rev Immunol,2005,5(3):215-229.
  • 7Hohn H,Ncukirch C,Freitag K,et al.Longitudinal analysisof the T-cell receptor(TCR)-Vαand-Vβrepertoire in CD8+T cellsfrom individuals immunized with recombinant hepatitis B surfaceantigen[J].Clin Exp Immunol,2002,129(2):309-317.
  • 8Das A,Hoare M,Davies N,et al.Functional skewing ofthe global CD8 T cell population in chronic hepatitis B virusinfection[J].J Exp Med,2008,205(9):2111-2124.
  • 9Mandruzzato S,Rossi E,Bernardi F,et al.Large anddissimilar repertoire of Melan-A/MART-1-specific CTL inmetastatic lesions and blood of a melanoma patient[J].ImmuungCancer,1998,21:27-36.
  • 10Semino C,Cilli M,Rstto GB,et al.Limit dilution analysisof peripheral blood lymphocytes reacting with non-small celllung cancer:Functionally heterogeneous effectors efficiently lyseautologous cancer cells[J].Int Immunol,2000,1(4):537-546.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部